In2Bones Launches Natural Alternative to Metal Implants

In2Bones Global Inc. has globally launched the AlloAid BioNail, an engineered, sterile allograft implant designed to provide rigid, stable fixation during reconstructive surgery of the hand and foot. 
 
Derived from strong cortical allograft, the AlloAid BioNail provides osteoconductive properties to encourage bone remodeling and healing, thus enabling a more natural fixation. In2Bones’ design—a tapered point and multiple, contoured wedge facets—eases insertion, anchors the implant into a fusion site, and acts as a compressive force to aid fixation. 
 
Unlike traditional solid metallic implants that provide no biologic benefit (metal implants do not remodel, requiring bone to heal around the device), the new AlloAid BioNail allografts are resorbed gradually by the surrounding bone. This eliminates many post-operative complications and greatly reduces the need for the implant to be removed—both common problems with metal implants. The natural, engineered allograft also makes the BioNail viable for patients with known metal allergies.
 
For surgeons, the new implant offers several advantages. “The BioNail is preferred over metal implants for fixating bunions for a few reasons,” said Dr. Amber Shane of Orlando Foot & Ankle Clinic. “Native bone incorporation is made possible by osteoconductive and osteoinductive properties at the fusion site, and, the implant’s radiolucent nature allows for better monitoring of bone healing during the perioperative period. In addition, the simple surgical steps save valuable OR time compared to placing screws. As surgeons, we are always thinking about options for patients should further surgery be needed. With the BioNail, revision osteotomies are possible because no surgical voids are created.” 
 
The AlloAid BioNail implant is supplied sterile, in various sizes, with single-use surgical instrument kits.
 
Allograft implants have had a long and successful clinical history, and are currently used in multiple applications and thousands of procedures annually. In2Bones is the market leader in engineered sterile allografts, with additional applications for hammertoe surgery and DIP finger joint fusions. 
 
The AlloAid BioNail is the sixth In2Bones sterile allograft product commercialized under the brand name AlloAid. It demonstrates In2Bones’ commitment to expanding the extremities market by launching innovative technological advancements to improve surgical outcomes and patient care.
 
Headquartered in Memphis, Tennessee, In2Bones is a global designer, manufacturer, and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities.